Merel M C Lambregts (Merel Lambregts)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Topics

Staphylococcus Aureus

Helicobacter Pylori

Urinary Tract Infection

Top Venues

JAC-antimicrobial resistance

Open forum infectious diseases

Antibiotics (Basel, Switzerland)

International journal of clinical practice

This page only lists publications with an associated author ORCID identifier.

Publications

Manu P Bilsen, Rosa M H Jongeneel, Caroline Schneeberger, Tamara N Platteel, Daniel Johannes Touw, Lona Mody, Jeffrey M Caterino, Suzanne E Geerlings, Bela Köves, Florian Wagenlehner, Simon Paul Conroy, Leo G Visser, Merel M C Lambregts
Definitions of Urinary Tract Infection in Current Research: A Systematic Review. Open forum infectious diseases 10 (7) (2023)
Manu P Bilsen, Janneke I M van Uhm, Janneke E Stalenhoef, Daniel Johannes Touw, Rolf H H Groenwold, Leo G Visser, Merel M C Lambregts
Intravesical aminoglycoside instillations as prophylaxis for recurrent urinary tract infection: patient satisfaction, long-term safety and efficacy. JAC-antimicrobial resistance 5 (2) (2023)
Annette C Westgeest, Emile F Schippers, Martijn Sijbom, Leo G Visser, Mark G J de Boer, Mattijs E Numans, Merel M C Lambregts, null On Behalf Of The Mrsa Network Holland West
Exploring the Barriers in the Uptake of the Dutch MRSA 'Search and Destroy' Policy Using the Cascade of Care Approach. Antibiotics (Basel, Switzerland) 11 (9) (2022)
Merel M C Lambregts, Babette Rump, Fabienne Ropers, Martijn Sijbom, Mariska Petrignani, Leo Visser, Martine de Vries, Mark de Boer
Antimicrobial guidelines in clinical practice: incorporating the ethical perspective. JAC-antimicrobial resistance 3 (2) (2021)
Merel M C Lambregts, Eva B D Molendijk, Soufian Meziyerh, Emile F Schippers, Nathalie M Delfos, Masja Leendertse, Alexandra T Bernards, Leo G Visser, Olaf M Dekkers, Mark G J de Boer
Early differentiation between uncomplicated and complicated Staphylococcus aureus bacteraemia: Potential value and limitations of a clinical risk score. International journal of clinical practice 74 (11) (2020)
Merel M C Lambregts, Alexandra T Bernards, Martha T van der Beek, Leo G Visser, Mark G de Boer
Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy. PloS one 14 (1) (2019)
Merel M C Lambregts, Bart J C Hendriks, Leo G Visser, Sandra T Bernards, Mark G J de Boer
Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study. Antimicrobial resistance and infection control 8 (2019)
Merel M C Lambregts, Eva B Warreman, Alexandra T Bernards, Hendrik Veelken, Peter A von dem Borne, Olaf M Dekkers, Leo G Visser, Mark G de Boer
Distribution and clinical determinants of time-to-positivity of blood cultures in patients with neutropenia. European journal of haematology 100 (2) (2017)